Naslov
Modern antiplatelet management of coronary artery bypass patients : a role of platelet function testing in decision making

Autori
Petričević, Mate ; Biočina, Bojan ; Safradin, Ivica ; Miličić, Davor

Izvornik
Journal of thrombosis and thrombolysis (0929-5305) 37 (2013), 3; 249-250

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, stručni

Ključne riječi
antiplatelet therapy; coronary artery bypass surgery

Sažetak
We read with great interest the recently published study by Williams et al. [1]. The authors sought to determine the relationship between postoperative clopidogrel and clinical and angiographic outcomes following coronary artery bypass grafting (CABG) [1]. Although clopidogrel is now recommended as postoperative antiplatelet therapy in patients with recent acute coronary syndromes, some other circumstances such as off-pump CABG, performed endarterectomy, and extensive severe coronary artery disease with small target vessels, warrant the use of both clopidogrel and aspirin following surgical revascularization [2]. In present study by Williams et al. [1], postoperative antiplatelet therapy was left to physician discretion, thus creating patient selection bias since above mentioned circumstances requiring dual antiplatelet therapy (dAPT) could influence angiographic as well as clinical outcomes.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA